Latest News and Info

A clinical pharmacist discusses medication management with a patient in a primary care setting.

Medicines Optimisation vs Medicines Management in the UK

Medicines management focuses on the systems and governance of prescribing, while medicines optimisation is a person-centred approach aimed at improving patient outcomes and clinical value in primary care. In UK primary care, optimisation builds on management processes to ensure medicines deliver measurable clinical value. Understanding the difference between medicines management and optimisation is essential for PCNs, ICBs and practice leaders.

Medicines optimisation is a core part of delivering safe and effective care in primary care. For a deeper look at how medicines optimisation services support GP practices and PCNs, explore our medicines optimisation services.

Key Takeaways

  • Focus on Outcomes: The core of medicines optimisation vs medicines management is the shift from process to patient outcomes and value.
  • Patient-Centred: Optimisation is a person-centred approach involving shared decision-making, unlike the system-focused nature of management.
  • Broader Scope: The clinical pharmacist role in medicines optimisation includes activities like deprescribing and adherence support, which go beyond traditional management.
Integrated Care Board (ICB) and GP practice workflow for medication optimisation.
Diagram showing levels of primary care collaboration from ICB to clinical pharmacist.

What is Medicines Management?

Medicines management refers to the traditional systems that govern how medicines are prescribed and monitored. As cited in the NICE guideline on medicines optimisation, it was originally defined as “a system of processes and behaviours that determines how medicines are used by the NHS and patients.” This is the essential foundation for safe medicine use. In UK primary care, particularly within PCNs and ICBs, the distinction affects workforce planning, ARRS utilisation, and service delivery.

Side-by-side comparison table showing differences between medicines management and medicines optimisation
A practical comparison of process-focused management versus outcome-focused optimisation.

What is Medicines Optimisation UK?

So, what is medicines optimisation UK? It is a broader concept that puts the patient at the centre of their care. NICE defines it as a “person-centred approach to safe and effective medicines use, to ensure people obtain the best possible outcomes from their medicines.”

The Royal Pharmaceutical Society (RPS) outlines four core medicines optimisation principles: understanding the patient’s experience, using evidence-based choices, ensuring safe use, and making optimisation part of routine practice. Answering ‘what is medicines optimisation UK?’ requires acknowledging these principles.

Expert insight from Adeem Azhar, qualified Clinical Pharmacist and CEO

The clinical pharmacist role in medicines optimisation is pivotal. When PCNs invest properly in their clinical pharmacy workforce, patient outcomes improve. That is where optimisation moves beyond management.

Adeem Azhar, MPharm, IPres
Co-Founder and Chief Executive Officer – Core Prescribing Solutions
Qualified Clinical Pharmacist

This is where structured medicines optimisation services deliver measurable improvements in patient outcomes and prescribing efficiency.

Circular infographic showing four medicines optimisation principles: patient experience, evidence-based choice, safe use and routine optimisation
The four principles outlined by the Royal Pharmaceutical Society underpin optimisation in UK practice.

Medicines Optimisation vs Medicines Management: A Comparison

The simplest way to understand the difference between medicines management and optimisation is to think of management as how the machine runs and optimisation as whether the machine is improving lives. This is clear when comparing a structured medication review vs medicines management.

Medicines ManagementMedicines Optimisation
Focuses on systems and governanceFocuses on patient outcomes
Prescribing auditsStructured Medication Reviews
Compliance and processShared decision-making
Operational efficiencyClinical value and safety

This practical distinction is central to the medicines optimisation vs medicines management debate.

Illustration comparing structured medication review consultation with administrative medicines management task
A structured medication review is a clinical optimisation activity, not just a management process.

FAQs

Clinical pharmacist with callouts showing deprescribing, polypharmacy review, adherence support and safety monitoring
Clinical pharmacists deliver the practical work of medicines optimisation in PCNs.

Moving from Medicines Management to True Medicines Optimisation

Pharmacist and pharmacy technician arranging monitored dosage system blister packs with calendar and clock icons symbolising timed medication dosing.

Monitored Dosage Systems (MDS) – What They Are and How They Support Safer Medicines Management

Managing multiple medicines safely can be challenging – particularly in care homes and for patients with long-term conditions or complex prescriptions. One tool often used to support this is the Monitored Dosage System (MDS), often referred to as MDS medication in the UK, and also known as a dosette box, blister pack, basic pack, or multi-compartment compliance aid (MCA).

These systems aim to make medicines easier to administer, safer for carers, and more manageable for patients. But while MDS have clear benefits, they also come with limitations. UK guidance from the NHS, NICE, and the CQC now encourages a more person-centred approach to medicines management.

Key Takeaways

  1. MDS are helpful but not universal – Monitored Dosage Systems can support safe medicine administration, but they aren’t suitable for every patient or medication. Individual assessment is essential.
  2. UK guidance prioritises person-centred care – NICE, CQC, and the RPS recommend original packs with support as the default, with MDS used only where there’s clear need.
  3. Core Prescribing Solutions helps organisations get it right – Core Prescribing Solutions pharmacists and pharmacy technicians deliver reviews, staff training, and governance support to ensure medicines systems are safe, efficient, and aligned with best practice.

What Is a Monitored Dosage System?

A Monitored Dosage System (MDS) is a device that organises a patient’s medicines into compartments divided by days of the week and times of day.

Pharmacists or dispensing doctors prepare the packs by repackaging tablets and capsules from their original containers into trays or blister packs.

Monitored Dosage System also known as:

  • Multi-compartment compliance aid (MCA)
  • Dosette box
  • Blister pack
  • Basic pack

These terms are often used interchangeably, though “MDS” usually refers to pharmacy-prepared blister packs rather than the simpler pill organisers that patients can fill themselves.

Medication management and prescribing solutions for healthcare professionals.

Types of Monitored Dosage Systems

Monitored Dosage Systems come in two main forms:

Pharmacy-prepared blister packs

  • Plastic trays or cassettes sealed with foil
  • Each compartment labelled with the day and time of dose
  • Prepared weekly or monthly by a pharmacist or trained pharmacy technician

Manual pill organisers (dosette boxes/basic packs)

  • Reusable plastic containers with compartments
  • Typically filled by patients or carers at home
  • Not suitable for formal care settings, as only pharmacists or dispensing doctors can legally fill trays for professional use

Examples of MDS in practice:

  • A weekly blister pack with four daily slots (morning, lunchtime, evening, bedtime)
  • A once-daily pack for a patient on fewer medicines
  • Multi-week trays designed for care home use
Young female healthcare professional dispensing medication to elderly woman patient.

Monitored Dosage Systems in Care Homes

MDS have long been common in UK care homes. Many providers adopted blister packs for residents, believing they reduced errors and sped up medication rounds.

Today, regulators advise against using MDS for every resident as a default. Instead, decisions should be based on individual need and independence. Care homes using MDS must also manage:

  • Medicines unsuitable for blister packs (kept in original packaging)
  • Prescription changes mid-cycle (which may require new trays)
  • Staff training on safe administration and documentation

The Care Quality Commission (CQC) looks for evidence that care homes have robust policies for whichever system they use, whether that’s original packs, MDS, or a combination.

Benefits of a Monitored Dosage System

Monitored Dosage Systems help patients take their medications correctly and on time. Proper mds medicationmanagement can significantly improve adherence and reduce the risk of medication errors.

When used appropriately, MDS can provide several advantages:

  • Simplifies administration – medicines are pre-sorted into the correct times and days.
  • Improves adherence – supports patients with memory problems, poor eyesight, or dexterity issues.
  • Supports carers – speeds up medication rounds and provides a visual record of doses given.
  • Promotes independence – some patients can self-manage more confidently using an MDS.
  • Reduces risk in certain situations – such as overdose prevention, or when frequent dose changes make weekly supply safer.

Drugs Not Suitable for Monitored Dosage Systems

Not all medicines can be repackaged into an MDS tray. Some must remain in original packaging to maintain stability or because of their formulation. These include:

  • Liquids, syrups, and suspensions
  • Inhalers and nasal sprays
  • Creams, ointments, and eye drops
  • Effervescent and dispersible tablets
  • Controlled drugs requiring strict handling
  • “As required” (PRN) medicines, such as pain relief taken only when needed
  • Hygroscopic or light-sensitive tablets (e.g. some antibiotics, effervescent formulations)

This often means patients – particularly in care homes – still need a mix of MDS and original packs, requiring carers to manage both systems side by side.

Drawbacks and Challenges of MDS

Alongside drug suitability issues, MDS have wider challenges:

  • No guaranteed error reduction – studies like the CHUMS report show MDS don’t consistently lower medication error rates.
  • New risks introduced – repackaging can lead to labelling mistakes or trays filled incorrectly.
  • De-skilling staff – carers may over-rely on trays, reducing their medicines knowledge.
  • Extra workload and costs – pharmacies receive no extra NHS funding for preparing trays; GPs may need to issue 7-day scripts, increasing workload.
  • Inflexibility – any prescription changes mid-cycle often mean trays must be replaced, creating waste.

UK Guidance and Best Practice

  • NICE SC1 (Care homes): Choose systems based on individual need, aiming to maintain independence.
  • NICE NG67 (Community): Only use MDS when a health professional has assessed and identified a clear need.
  • Royal Pharmaceutical Society (RPS): Original packs with support should be the default; MDS only when necessary.
  • CQC: Care homes must have clear policies for managing MDS and medicines not in trays, with regular reviews of use.
  • Equality Act 2010: Pharmacies must make reasonable adjustments for patients with disabilities – MDS may be one option, but not the only one.

The Role of Pharmacists, Pharmacy Technicians, Prescribers, and Care Teams

Pharmacists

  • Assess patient suitability for MDS
  • Provide clinical oversight of medicines and adherence strategies
  • Review ongoing use regularly
  • Deliver clinical pharmacist support to GP practices and PCNs

Pharmacy Technicians

  • Often prepare and check MDS trays under pharmacist supervision
  • Support medicines reconciliation and documentation
  • Provide training and practical advice to care staff on administering medicines safely
  • Play a key role in freeing up pharmacists’ time for medicines optimisation while ensuring medicines are dispensed accurately and efficiently

Prescribers (GPs and clinicians)

  • Adjust prescription intervals (e.g. weekly scripts) if needed
  • Optimise regimens to reduce complexity
  • Work with pharmacists during medication reviews

Care staff and carers

  • Administer medicines safely using MAR charts
  • Manage both trays and original packs where required
  • Communicate issues or changes back to prescribers and pharmacy teams
Efficient collaboration between healthcare professionals in a clinical setting.

How Core Prescribing Solutions (CPS) Supports Medicines Management

At Core Prescribing Solutions, our team of clinical pharmacists and pharmacy technicians provides expertise to GP practices, PCNs, and care providers across the UK.

We help by:

  • Medicines optimisation reviews – simplifying regimens, identifying when MDS is truly needed, and deprescribing where appropriate.
  • Supporting prescribers – reducing GP workload by handling medication queries and coordinating with pharmacies.
  • Training care staff – ensuring confidence in administering from both MDS trays and original packs.
  • Ensuring compliance with guidance – aligning policies with NICE, CQC, and Equality Act expectations.
  • Combining pharmacist and technician expertise – Core Prescribing Solutions pharmacy technicians handle the practical aspects of medicines management (like preparing and checking MDS, supporting audits, and training), while pharmacists focus on clinical decision-making and optimisation. Together, they provide a complete solution for safe prescribing and administration.

Expert insight from Adeem Azhar, qualified Clinical Pharmacist and CEO

“Monitored Dosage Systems can be useful in the right circumstances, but they are not a universal solution. At Core Prescribing Solutions, we focus on assessing each patient individually – sometimes an MDS is the right answer, other times simplifying the prescription or providing alternative support works better. The priority is always safe, person-centred care that reduces risk while maintaining independence.”

By embedding this combined approach into everyday practice, Core Prescribing Solutions (CPS) helps healthcare organisations balance patient safety, independence, and efficiency – while also meeting regulatory requirements.

Adeem Azhar, MPharm, IPres
Co-Founder and Chief Executive Officer – Core Prescribing Solutions
Qualified Clinical Pharmacist

FAQs

Final Thoughts

Monitored Dosage Systems remain an important tool in UK healthcare – but they are not a universal solution. Used correctly, they can improve adherence and support carers. Used inappropriately, they can create complexity and waste.

The key is individual assessment and regular review. That’s where Core Prescribing Solutions comes in – providing the combined expertise of pharmacists and pharmacy technicians to ensure medicines systems are safe, efficient, and truly patient-centred.

Learn more about Core Prescribing Solutions services and support.

Copyright 2026.